Systematic Critical Review of Genetic Factors Associated with Cisplatin-induced Ototoxicity: Canadian Pharmacogenomics Network for Drug Safety 2022 Update.

Saved in:
Bibliographic Details
Title: Systematic Critical Review of Genetic Factors Associated with Cisplatin-induced Ototoxicity: Canadian Pharmacogenomics Network for Drug Safety 2022 Update.
Authors: Scott EN; BC Children's Hospital Research Institute, Vancouver, British Columbia, Canada.; Department of Medical Genetics, Faculty of Medicine, University of British Columbia (UBC), Vancouver, British Columbia, Canada., Joseph AA; BC Children's Hospital Research Institute, Vancouver, British Columbia, Canada.; Division of Translational Therapeutics, Department of Pediatrics, Faculty of Medicine, UBC, Vancouver, British Columbia, Canada., Dhanda A; BC Children's Hospital Research Institute, Vancouver, British Columbia, Canada.; Division of Translational Therapeutics, Department of Pediatrics, Faculty of Medicine, UBC, Vancouver, British Columbia, Canada., Tanoshima R; Department of Pediatrics, Yokohama City University Hospital, Yokohama, Japan.; YCU Center for Novel and Exploratory Clinical Trials, Yokohama City University Hospital, Yokohama, Japan., Brooks B; Audiology and Speech Pathology Department, British Columbia Children's Hospital, Vancouver, British Columbia, Canada.; School of Audiology and Speech Science, UBC, Vancouver, British Columbia, Canada., Rassekh SR; BC Children's Hospital Research Institute, Vancouver, British Columbia, Canada.; Division of Oncology, Hematology and Bone Marrow Transplant, British Columbia Children's Hospital and UBC, Vancouver, British Columbia, Canada., Ross CJD; BC Children's Hospital Research Institute, Vancouver, British Columbia, Canada.; Department of Medical Genetics, Faculty of Medicine, University of British Columbia (UBC), Vancouver, British Columbia, Canada.; Faculty of Pharmaceutical Sciences, UBC, Vancouver, British Columbia, Canada., Carleton BC; BC Children's Hospital Research Institute, Vancouver, British Columbia, Canada.; Department of Medical Genetics, Faculty of Medicine, University of British Columbia (UBC), Vancouver, British Columbia, Canada.; Division of Translational Therapeutics, Department of Pediatrics, Faculty of Medicine, UBC, Vancouver, British Columbia, Canada.; Pharmaceutical Outcomes Programme, British Columbia Children's Hospital, Vancouver, British Columbia, Canada; and., Loucks CM; BC Children's Hospital Research Institute, Vancouver, British Columbia, Canada.; Division of Translational Therapeutics, Department of Pediatrics, Faculty of Medicine, UBC, Vancouver, British Columbia, Canada.; Department of Anesthesiology, Pharmacology & Therapeutics, Faculty of Medicine, UBC, Vancouver, British Columbia, Canada.
Source: Therapeutic drug monitoring [Ther Drug Monit] 2023 Dec 01; Vol. 45 (6), pp. 714-730. Date of Electronic Publication: 2023 Jul 13.
Publication Type: Systematic Review; Journal Article
Journal Info: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 7909660 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1536-3694 (Electronic) Linking ISSN: 01634356 NLM ISO Abbreviation: Ther Drug Monit Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1536-3694
DOI:10.1097/FTD.0000000000001113